Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 376

1.

Titanium oxide nanotube arrays for high light extraction efficiency of GaN-based vertical light-emitting diodes.

Leem YC, Seo O, Jo YR, Kim JH, Chun J, Kim BJ, Noh DY, Lim W, Kim YI, Park SJ.

Nanoscale. 2016 Apr 28. [Epub ahead of print]

PMID:
27121775
2.

Oncologic Safety of Immediate Breast Reconstruction for Invasive Breast Cancer Patients: A Matched Case Control Study.

Park SH, Han W, Yoo TK, Lee HB, Jin US, Chang H, Minn KW, Noh DY.

J Breast Cancer. 2016 Mar;19(1):68-75. doi: 10.4048/jbc.2016.19.1.68. Epub 2016 Mar 25.

3.

Attribution to Heterogeneous Risk Factors for Breast Cancer Subtypes Based on Hormone Receptor and Human Epidermal Growth Factor 2 Receptor Expression in Korea.

Park B, Choi JY, Sung HK, Ahn C, Hwang Y, Jang J, Lee J, Kim H, Shin HR, Park S, Han W, Noh DY, Yoo KY, Kang D, Park SK.

Medicine (Baltimore). 2016 Apr;95(14):e3063. doi: 10.1097/MD.0000000000003063.

4.

Synthesis of nanofibrous gelatin/silica bioglass composite microspheres using emulsion coupled with thermally induced phase separation.

Noh DY, An YH, Jo IH, Koh YH, Kim HE.

Mater Sci Eng C Mater Biol Appl. 2016 May 1;62:678-85. doi: 10.1016/j.msec.2016.02.017. Epub 2016 Feb 4.

PMID:
26952472
5.

Erratum to: Population attributable risks of modifiable reproductive factors for breast and ovarian cancers in Korea.

Park B, Park S, Shin HR, Shin A, Yeo Y, Choi JY, Jung KW, Kim BG, Kim YM, Noh DY, Ahn SH, Kim JW, Kang S, Kim JH, Kim TJ, Kang D, Yoo KY, Park SK.

BMC Cancer. 2016 Mar 4;16(1):181. doi: 10.1186/s12885-016-2216-2. No abstract available.

6.

New insight on the biological role of p53 protein as a tumor suppressor: re-evaluation of its clinical significance in triple-negative breast cancer.

Jin MS, Park IA, Kim JY, Chung YR, Im SA, Lee KH, Moon HG, Han W, Noh DY, Ryu HS.

Tumour Biol. 2016 Feb 19. [Epub ahead of print]

PMID:
26894602
7.

Identifying the potential long-term survivors among breast cancer patients with distant metastasis.

Lee ES, Jung SY, Kim JY, Kim JJ, Yoo TK, Kim YG, Lee KS, Lee ES, Kim EK, Min JW, Han W, Noh DY, Moon HG.

Ann Oncol. 2016 May;27(5):828-33. doi: 10.1093/annonc/mdw036. Epub 2016 Jan 28.

8.

Population attributable risks of modifiable reproductive factors for breast and ovarian cancers in Korea.

Park B, Park S, Shin HR, Shin A, Yeo Y, Choi JY, Jung KW, Kim BG, Kim YM, Noh DY, Ahn SH, Kim JW, Kang S, Kim JH, Kim TJ, Kang D, Yoo KY, Park SK.

BMC Cancer. 2016 Jan 6;16:5. doi: 10.1186/s12885-015-2040-0.

9.

Adherence to Guidelines for Cancer Survivors and Health-Related Quality of Life among Korean Breast Cancer Survivors.

Song S, Hwang E, Moon HG, Noh DY, Lee JE.

Nutrients. 2015 Dec 9;7(12):10307-19. doi: 10.3390/nu7125532.

10.

The Clinical Significance and Molecular Features of the Spatial Tumor Shapes in Breast Cancers.

Moon HG, Kim N, Jeong S, Lee M, Moon H, Kim J, Yoo TK, Lee HB, Kim J, Noh DY, Han W.

PLoS One. 2015 Dec 15;10(12):e0143811. doi: 10.1371/journal.pone.0143811. eCollection 2015.

11.

In Vivo Tumor Growth Rate Measured by US in Preoperative Period and Long Term Disease Outcome in Breast Cancer Patients.

Yoo TK, Min JW, Kim MK, Lee E, Kim J, Lee HB, Kang YJ, Kim YG, Moon HG, Moon WK, Cho N, Noh DY, Han W.

PLoS One. 2015 Dec 10;10(12):e0144144. doi: 10.1371/journal.pone.0144144. eCollection 2015.

12.

Oncogenic role of SIRT1 associated with tumor invasion, lymph node metastasis, and poor disease-free survival in triple negative breast cancer.

Chung SY, Jung YY, Park IA, Kim H, Chung YR, Kim JY, Park SY, Im SA, Lee KH, Moon HG, Noh DY, Han W, Lee C, Kim TY, Ryu HS.

Clin Exp Metastasis. 2016 Feb;33(2):179-85. doi: 10.1007/s10585-015-9767-5. Epub 2015 Nov 19.

PMID:
26585892
13.

Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy.

Kim H, Youk J, Yang Y, Kim TY, Min A, Ham HS, Cho S, Lee KH, Keam B, Han SW, Oh DY, Ryu HS, Han W, Park IA, Kim TY, Noh DY, Im SA.

J Cancer Res Clin Oncol. 2016 Mar;142(3):707-14. doi: 10.1007/s00432-015-2072-5. Epub 2015 Nov 18.

PMID:
26577828
14.

Delay of Treatment Initiation Does Not Adversely Affect Survival Outcome in Breast Cancer.

Yoo TK, Han W, Moon HG, Kim J, Lee JW, Kim MK, Lee E, Kim J, Noh DY.

Cancer Res Treat. 2015 Oct 22. doi: 10.4143/crt.2015.173. [Epub ahead of print]

15.

Development and Validation of a Novel Plasma Protein Signature for Breast Cancer Diagnosis by Using Multiple Reaction Monitoring-based Mass Spectrometry.

Lee HB, Kang UB, Moon HG, Lee J, Lee KM, Yi M, Park YS, Lee JW, Yu JH, Choi SH, Cho SH, Lee C, Han W, Noh DY.

Anticancer Res. 2015 Nov;35(11):6271-9.

PMID:
26504062
16.

Erratum: The Basic Facts of Korean Breast Cancer in 2011: Results of a Nationwide Survey and Breast Cancer Registry Database.

Kim Z, Min SY, Yoon CS, Lee HJ, Lee JS, Youn HJ, Park HK, Noh DY, Hur MH; Korean Breast Cancer Society.

J Breast Cancer. 2015 Sep;18(3):301. doi: 10.4048/jbc.2015.18.3.301. Epub 2015 Sep 24.

17.

A Possible Association Between Thyroid Cancer and Breast Cancer.

An JH, Hwangbo Y, Ahn HY, Keam B, Lee KE, Han W, Park do J, Park IA, Noh DY, Youn YK, Cho BY, Im SA, Park YJ.

Thyroid. 2015 Dec;25(12):1330-8. doi: 10.1089/thy.2014.0561. Epub 2015 Oct 27.

PMID:
26442580
18.

Prognostic and functional importance of the engraftment-associated genes in the patient-derived xenograft models of triple-negative breast cancers.

Moon HG, Oh K, Lee J, Lee M, Kim JY, Yoo TK, Seo MW, Park AK, Ryu HS, Jung EJ, Kim N, Jeong S, Han W, Lee DS, Noh DY.

Breast Cancer Res Treat. 2015 Nov;154(1):13-22. doi: 10.1007/s10549-015-3585-y. Epub 2015 Oct 5.

PMID:
26438141
19.

A novel role for flotillin-1 in H-Ras-regulated breast cancer aggressiveness.

Koh M, Yong HY, Kim ES, Son H, Jeon YR, Hwang JS, Kim MO, Cha Y, Choi WS, Noh DY, Lee KM, Kim KB, Lee JS, Kim HJ, Kim H, Kim HH, Kim EJ, Park SY, Kim HS, Moon WK, Choi Kim HR, Moon A.

Int J Cancer. 2016 Mar 1;138(5):1232-45. doi: 10.1002/ijc.29869. Epub 2015 Oct 9.

PMID:
26413934
20.

Shear-Wave Elastography for the Detection of Residual Breast Cancer After Neoadjuvant Chemotherapy.

Lee SH, Chang JM, Han W, Moon HG, Koo HR, Gweon HM, Kim WH, Noh DY, Moon WK.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S376-84. doi: 10.1245/s10434-015-4828-1. Epub 2015 Aug 22.

PMID:
26297209
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk